{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:55:11Z","timestamp":1791568511190,"version":"4.3.4"},"reference-count":82,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["AIDS Patient Care and STDs"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:p>HIV disproportionately impacts US racial and ethnic minorities but they participate in treatment and vaccine clinical trials at a lower rate than whites. To summarize barriers and facilitators to this participation we conducted a scoping review of the literature guided by the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines. Studies published from January 2007 and September 2019 were reviewed. Thirty-one articles were identified from an initial pool of 325 records using three coders. All records were then assessed for barriers and facilitators and summarized. Results indicate that while racial and ethnic minority participation in these trials has increased over the past 10 years, rates still do not proportionately reflect their burden of HIV infection. While many of the barriers mirror those found in other disease clinical trials (e.g., cancer), HIV stigma is a unique and important barrier to participating in HIV clinical trials. Recommendations to improve recruitment and retention of racial and ethnic minorities include training health care providers on the importance of recruiting diverse participants, creating interdisciplinary research teams that better represent who is being recruited, and providing culturally competent trial designs. Despite the knowledge of how to better recruit racial and ethnic minorities, few interventions have been documented using these strategies. Based on the findings of this review, we recommend that future clinical trials engage community stakeholders in all stages of the research process through community-based participatory research approaches and promote culturally and linguistically appropriate recruitment and retention strategies for marginalized populations overly impacted by HIV.<\/jats:p>","DOI":"10.1089\/apc.2020.0008","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T14:28:14Z","timestamp":1600180094000},"page":"399-416","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":48,"title":["Exploring the Engagement of Racial and Ethnic Minorities in HIV Treatment and Vaccine Clinical Trials: A Scoping Review of Literature and Implications for Future Research"],"prefix":"10.1177","volume":"34","author":[{"given":"Sarah Bauerle","family":"Bass","sequence":"first","affiliation":[{"name":"Risk Communication Laboratory, Department of Social and Behavioral Sciences, Temple University College of Public Health, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"D'Avanzo","sequence":"additional","affiliation":[{"name":"Risk Communication Laboratory, Department of Social and Behavioral Sciences, Temple University College of Public Health, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alhajji","sequence":"additional","affiliation":[{"name":"Risk Communication Laboratory, Department of Social and Behavioral Sciences, Temple University College of Public Health, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Ventriglia","sequence":"additional","affiliation":[{"name":"Fox Chase Cancer Center, Risk Assessment Program, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Trainor","sequence":"additional","affiliation":[{"name":"Risk Communication Laboratory, Department of Social and Behavioral Sciences, Temple University College of Public Health, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Maurer","sequence":"additional","affiliation":[{"name":"Tennessee Department of Health, HIV\/STD\/Viral Hepatitis Section, Nashville, Tennessee, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Eisenberg","sequence":"additional","affiliation":[{"name":"Boston Medical Center, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Martinez","sequence":"additional","affiliation":[{"name":"School of Social Work, Temple University College of Public Health, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"e_1_3_4_2_2","unstructured":"Centers for Disease Control and Prevention . HIV Surveillance Report 2016; vol. 28. 2017. Available at: http:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html (Last accessed May24 2020)."},{"key":"e_1_3_4_3_2","unstructured":"Centers for Disease Control and Prevention. HIV Surveillance Report 2018 (Preliminary). 2018. Available at: http:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html"},{"key":"e_1_3_4_4_2","unstructured":"Centers for Disease Control and Prevention . HIV Surveillance Report 2017. 2018. Available at: http:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60899-X"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2012.701722"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.1343"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.2174\/1381612053764869"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2403.171797"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.13505"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2016.10.006"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/0095798403259243"},{"key":"e_1_3_4_13_2","unstructured":"National Institutes of Health. Amendment: NIH policy and guidelines on the inclusion of women and minorities as subjects in clinical research. 2017. Available at: https:\/\/grants.nih.gov\/grants\/guide\/notice-files\/NOT-OD-18-014.html"},{"key":"e_1_3_4_14_2","unstructured":"White House Office of National AIDS Policy. National HIV\/AIDS Strategy for the United States: Updated to. 2020. 2015. Available at: https:\/\/www.aids.gov\/federal-resources\/national-hiv-aids-strategy\/nhas-update.pdf"},{"key":"e_1_3_4_15_2","unstructured":"Centers for Medicare and Medicaid Services. Medicare Clinical Trial Policies. 2007. Available at: https:\/\/www.cms.gov\/Medicare\/Coverage\/ClinicalTrialPolicies\/index"},{"key":"e_1_3_4_16_2","first-page":"18S","article-title":"Participation of racial\/ethnic groups in clinical trials and race-related labeling: A review of new molecular entitites approved 1995\u20131999","volume":"93","author":"Evelyn B","year":"2001","unstructured":"Evelyn B, , Toigo T, , Banks D, et al. Participation of racial\/ethnic groups in clinical trials and race-related labeling: A review of new molecular entitites approved 1995\u20131999. J Natl Med Assoc, 2001; 93:18S.","journal-title":"J Natl Med Assoc"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-016-1322-4"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa011565"},{"key":"e_1_3_4_19_2","unstructured":"The Society for Women's Health Research United States Food and Drug Administration Office of Women's Health. Dialogues on Diversifying Clinical Trials; Successful Strategies for Engaging Women and Minorities in Clinical Trials. 2007. Available at: http:\/\/www.fda.gov\/downloads\/ScienceResearch\/SpecialTopics\/WomensHealthResearch\/UCM334959.pdf"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2018.11.002"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200411190-00003"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/0033354918814260"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02696655"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2003.22"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.1.130-137.2003"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.5414\/CPP42701"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1517\/17425250902800153"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181609da8"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2005.14.19"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-008-0494-6"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2012.752566"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.06.055"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310566"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113425"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1086\/425518"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181990605"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1310\/hct1501-14"},{"key":"e_1_3_4_38_2","first-page":"242","article-title":"Enrollment of racial\/ethnic minorities and women with HIV in clinical research studies of HIV medicines","volume":"99","author":"Sullivan PS","year":"2007","unstructured":"Sullivan PS, , McNaghten AD, , Begley E, et al. Enrollment of racial\/ethnic minorities and women with HIV in clinical research studies of HIV medicines. J Natl Med Assoc, 2007; 99:242\u2013250.","journal-title":"J Natl Med Assoc"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1080\/09540120500428952"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.14423\/SMJ.0000000000000234"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1258\/095646206775455667"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000189866.67182.f7"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030019"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00135"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1177\/001316447303300309"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2009.0008"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2015.1112352"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0027-9684(15)30558-7"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2009.0306"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-007-0121-8"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2011.0269"},{"key":"e_1_3_4_52_2","first-page":"242","article-title":"Enrollment of racial\/ethnic minorities and women with HIV in clinical research studies of HIV medicines","volume":"99","author":"Sullivan P","year":"2007","unstructured":"Sullivan P, , McNaghten AD, , Begley E, et al. Enrollment of racial\/ethnic minorities and women with HIV in clinical research studies of HIV medicines. J Natl Med Assoc, 2007; 99:242\u2013250.","journal-title":"J Natl Med Assoc"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2006.0234"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1353\/cpr.2012.0023"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-012-0151-z"},{"key":"e_1_3_4_56_2","first-page":"254","article-title":"Why blacks do not take part in HIV vaccine trials","volume":"99","author":"Moutsiakis D","year":"2007","unstructured":"Moutsiakis D, , Chin NP. Why blacks do not take part in HIV vaccine trials. J Natl Med Assoc, 2007; 99:254\u2013257.","journal-title":"J Natl Med Assoc"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jana.2010.10.007"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1080\/09540120701866992"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.4278\/ajhp.130125-QUAL-48"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.2174\/157016212800792531"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.06.082"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2006.12.007"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181702"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-013-2554-6"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2013.301653"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1080\/09540120600872711"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000179454.93443.60"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.06.064"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1093\/her\/cys013"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1177\/1090198112452124"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-009-9539-9"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2010.196048"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1093\/her\/cyt052"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-014-0829-5"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6113.1000648"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1177\/1744987117699655"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1093\/hsw\/hlz008"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11121-009-0162-9"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1177\/1557988315579195"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jana.2017.11.003"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2018.0282"},{"key":"e_1_3_4_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jana.2010.10.008"},{"key":"e_1_3_4_83_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002534"}],"container-title":["AIDS Patient Care and STDs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/apc.2020.0008","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/apc.2020.0008","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/apc.2020.0008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:04:03Z","timestamp":1777399443000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/apc.2020.0008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":82,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1089\/apc.2020.0008"],"URL":"https:\/\/doi.org\/10.1089\/apc.2020.0008","relation":{},"ISSN":["1087-2914","1557-7449"],"issn-type":[{"value":"1087-2914","type":"print"},{"value":"1557-7449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}